We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Biheldon cat and dog wormers seized at East Midlands Airport.
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Groups of ODS with their ozone-depleting potential.
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
Information for healthcare professionals and the public about the Pfizer/BioNTech's bivalent vaccines
The diagnosis, management and surveillance of extended-spectrum beta-lactamases (ESBLs).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to spot brucellosis, what to do if you suspect it and measures to prevent its spread
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
Amphotericin B (AmB) is used to treat a neglected disease called visceral leishmaniasis
Information about benzyl chloride for use in responding to chemical incidents.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).